ArticleLeukemia research reports2025

Rapid development of Philadelphia chromosome-negative AML in a CML patient with sustained major molecular response to tyrosine kinase inhibitor therapy.

Huan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.